Effect of A Disintegrin and Metalloproteinase 10 Gene Silencing on the Proliferation, Invasion and Migration of the Human Tongue Squamous Cell Carcinoma Cell Line TCA8113

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2014 Oct 22

PMID 25333745

Citations 2

Authors

Yuan Shao

Xiao-Ying Sha

Yan-Xia Bai

Fang Quan

Sheng-Li Wu

Affiliations

Soon will be listed here.

Abstract

The present study aimed to investigate the effect of A disintegrin and metalloproteinase 10 (ADAM10) gene silencing on the proliferation, migration and invasion of the human tongue squamous cell carcinoma cell line TCA8113. RNA interference was used to knock down the expression of ADAM10 in the TCA8113 cell line and the proliferation, migration and invasive ability of the treated cells were observed in vitro. The expression levels of epidermal growth factor receptor (EGFR) and E-cadherin in the treated cells were determined by western blot analysis. The proliferation, migration and invasion abilities of cells in the ADAM10 siRNA-treated group were significantly lower than those in the control groups (P<0.05). In addition, compared with the control groups, the expression levels of EGFR and E-cadherin in the ADAM10 siRNA-treated cells were significantly decreased (P<0.05) and increased (P<0.05), respectively. These results suggested that ADAM10 is important in regulating the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113 and that the mechanism may, at least in part, be associated with the upregulation of EGFR and the downregulation of E-cadherin.

Citing Articles

Potential impact of ADAM-10 genetic variants with the clinical features of oral squamous cell carcinoma.

Chen Y, Lin C, Chou Y, Su S, Chang L, Lee C J Cell Mol Med. 2023; 27(8):1144-1152.

PMID: 36946281 PMC: 10098292. DOI: 10.1111/jcmm.17728.

The Occurrence of MET Ectodomain Shedding in Oral Cancer and Its Potential Impact on the Use of Targeted Therapies.

De Herdt M, van der Steen B, Baatenburg de Jong R, Looijenga L, Koljenovic S, Hardillo J Cancers (Basel). 2022; 14(6).

PMID: 35326642 PMC: 8946088. DOI: 10.3390/cancers14061491.

References

Prox J, Willenbrock M, Weber S, Lehmann T, Schmidt-Arras D, Schwanbeck R . Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10. Cell Mol Life Sci. 2012; 69(17):2919-32. PMC: 11114675. DOI: 10.1007/s00018-012-0960-2. View

Myers J, Elkins T, Roberts D, Byers R . Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg. 2000; 122(1):44-51. DOI: 10.1016/S0194-5998(00)70142-2. View

Millichip M, Dallas D, Wu E, Dale S, McKie N . The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun. 1998; 245(2):594-8. DOI: 10.1006/bbrc.1998.8485. View

Hernandez-Guerrero J, Jacinto-Aleman L, Jimenez-Farfan M, Macario-Hernandez A, Hernandez-Flores F, Alcantara-Vazquez A . Prevalence trends of oral squamous cell carcinoma. Mexico City's General Hospital experience. Med Oral Patol Oral Cir Bucal. 2013; 18(2):e306-11. PMC: 3613885. DOI: 10.4317/medoral.18043. View

Bagan J, Sarrion G, Jimenez Y . Oral cancer: clinical features. Oral Oncol. 2010; 46(6):414-7. DOI: 10.1016/j.oraloncology.2010.03.009. View

Ebsen H, Schroder A, Kabelitz D, Janssen O . Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells. PLoS One. 2013; 8(10):e76853. PMC: 3793918. DOI: 10.1371/journal.pone.0076853. View

Jones A, Lambert D, Speight P, Whawell S . ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin. FEBS Lett. 2013; 587(21):3529-34. DOI: 10.1016/j.febslet.2013.09.010. View

Yu Y, Chen W, Zhang Y, Hamburger A, Pan H, Zhang Z . Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer. Int J Cancer. 2007; 120(9):1909-13. DOI: 10.1002/ijc.22541. View

Pan Y, Han C, Wang C, Hu G, Luo C, Gan X . ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1. J Mol Endocrinol. 2012; 49(1):21-33. DOI: 10.1530/JME-11-0174. View

10.

Doberstein K, Pfeilschifter J, Gutwein P . The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma. Carcinogenesis. 2011; 32(11):1713-23. DOI: 10.1093/carcin/bgr195. View

11.

Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello M . Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2005; 366(1):2-16. DOI: 10.1016/j.gene.2005.10.018. View

12.

Lin J, Luo J, Redies C . Differential expression of five members of the ADAM family in the developing chicken brain. Neuroscience. 2008; 157(2):360-75. DOI: 10.1016/j.neuroscience.2008.08.053. View

13.

Guo J, He L, Yuan P, Wang P, Lu Y, Tong F . ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway. Oncol Rep. 2012; 28(5):1709-18. DOI: 10.3892/or.2012.2003. View

14.

Gaida M, Haag N, Gunther F, Tschaharganeh D, Schirmacher P, Friess H . Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma. Int J Mol Med. 2010; 26(2):281-8. DOI: 10.3892/ijmm_00000463. View

15.

Shao Y, Zhang S, Quan F, Zhang P, Wu S . MicroRNA-145 inhibits the proliferation, migration and invasion of the human TCA8113 oral cancer line. Oncol Lett. 2013; 6(6):1636-1640. PMC: 3835314. DOI: 10.3892/ol.2013.1621. View

16.

Haddad R, Shin D . Recent advances in head and neck cancer. N Engl J Med. 2008; 359(11):1143-54. DOI: 10.1056/NEJMra0707975. View

17.

Yuan S, Lei S, Wu S . ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells. Oncol Rep. 2013; 30(4):1715-22. DOI: 10.3892/or.2013.2650. View

18.

Duffy M, Mullooly M, ODonovan N, Sukor S, Crown J, Pierce A . The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?. Clin Proteomics. 2011; 8(1):9. PMC: 3170276. DOI: 10.1186/1559-0275-8-9. View

19.

Armanious H, Gelebart P, Anand M, Belch A, Lai R . Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNFα/NFκB pathway. Blood. 2011; 117(23):6237-46. DOI: 10.1182/blood-2010-10-313940. View

20.

Zheng X, Jiang F, Katakowski M, Lu Y, Chopp M . ADAM17 promotes glioma cell malignant phenotype. Mol Carcinog. 2011; 51(2):150-64. PMC: 3234333. DOI: 10.1002/mc.20772. View